|
|
|
25.06.26 - 07:03
|
IBA to install the first proton therapy center in Brazil in Rio de Janeiro (GlobeNewswire EN)
|
|
|
Louvain-La-Neuve, Belgium, June 25, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract with the Fundação Severino Sombra (FUSVE), a non-profit philanthropic healthcare and educational institution responsible for the University of Vassouras and Hospital Mário Kroeff, for the purchase of a Proteus®ONE1 system....
|
|
|
24.06.26 - 15:27
|
Belgiens Geschäftsklima steigt im Juni (Dow Jones)
|
|
|
DOW JONES--Das belgische Geschäftsklima hat sich im Juni aufgehellt. Wie die Belgische Nationalbank (BNB) mitteilte, stieg der Index um 0,9 Punkte auf minus 12,4 Punkte. Das Geschäftsklima verbesserte sich deutlich in der Bauwirtschaft und im Handwerk ......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.06.26 - 07:03
|
Banqup Group Announces Strategic Simplification Plan and Launch of Process to Explore Strategic Alternatives (GlobeNewswire EN)
|
|
|
La Hulpe, Belgium - 15 June 2026, 7:00 a.m. CET – INSIDE INFORMATION - Banqup Group SA (Euronext Brussels: BANQ) (“Banqup” or the “Company”) today announces that, following an extensive review, the Board has approved a strategic simplification plan to reorganize the Group into distinct, autonomous business units to enhance operational focus and transparency. Lazard is mandated to explore all strategic options, including the sale of individual business units or the Group as a whole in order to maximize stakeholder value....
|
|
|
|
|
09.06.26 - 22:03
|
Lakefront Announces Initiation of €50 Million Stock Repurchase Program (GlobeNewswire EN)
|
|
|
Mechelen, Belgium; June 9, 2026, 22:01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced the launch of a share repurchase program (the “Program”), under which the Company may repurchase ordinary shares for an aggregate amount of up to €50 Million. Repurchases under the Program may be made no later than December 31, 2026. The Program is entered into with Morgan Stanley & Co International PLC. ...
|
|
|
|
|
08.06.26 - 22:03
|
Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer (GlobeNewswire EN)
|
|
|
Mechelen, Belgium; June 8, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that Eric Hedrick, MD has been appointed Chief Medical Officer. This expanded leadership role supports the Company's strategic transformation following its acquisition of Ouro Medicines operational assets announced on June 4, 2026.1 Eric will report to Henry Gosebruch, CEO and join the Company's Management Committee....
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
